SEC Form 4 · accession 0000891293-15-000059

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Finance & Administration

Period of report

Nov 19, 2015

Accepted (ET)

Nov 20, 2015 · 5:39 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Nov 19, 2015	S	800	$1.10	D	920,547	D
Common Stock	Nov 19, 2015	S	1,400	$1.105	D	919,147	D
Common Stock	Nov 19, 2015	S	3,800	$1.11	D	915,347	D
Common Stock	Nov 19, 2015	S	200	$1.115	D	915,147	D
Common Stock	Nov 19, 2015	S	1,000	$1.12	D	914,147	D
Common Stock	Nov 19, 2015	S	1,000	$1.125	D	913,147	D
Common Stock	Nov 19, 2015	S	1,200	$1.13	D	911,947	D
Common Stock	Nov 19, 2015	S	100	$1.135	D	911,847	D
Common Stock	Nov 19, 2015	S	806	$1.14	D	911,041	D
Common Stock	Nov 19, 2015	S	2,994	$1.145	D	908,047	D
Common Stock	Nov 19, 2015	S	500	$1.15	D	907,547	D
Common Stock	Nov 19, 2015	S	1,100	$1.155	D	906,447	D
Common Stock	Nov 19, 2015	S	100	$1.16	D	906,347	D
Common Stock	holding	—	—		—	37	I	Trust for children

No Table II lines on this filing.